Hot Product

News

page_banner

Syphilis Testing— A Searchlight for Health

Recently, the number of syphilis infections in Japan has surged, according to data released in Japan. As of August 7, the number of people infected with the sexually transmitted disease syphilis has risen sharply to 7,013 across Japan, the first time the number of infections may have exceeded 10,000 since statistics using existing methods began in 1999.

Syphilis Testing

Looking around the world, syphilis has been prevalent worldwide, with WHO estimating that there are about 12 million new cases worldwide each year, mainly in South and Southeast Asia and Sub-Saharan Africa. Syphilis has been growing rapidly in China in recent years, and has become the STD with the highest number of reported cases.

As a chronic, systemic sexually transmitted disease caused by the bacterium Treponema Pallidum subspecies pallidum, syphilis is most commonly spread through sexual activity and can be clinically manifested as stage I syphilis, stage II syphilis, stage III syphilis, latent syphilis and congenital syphilis. The skin and mucous membranes of syphilis patients contain Treponema Pallidum. People who do not have syphilis can get the disease if their skin or mucous membranes are slightly damaged during sexual contact with syphilis patients, rarely are transmitted through blood transfusions or routes. Syphilis patients with acquired syphilis in the primary stage are the source of infection. More than 95% are transmitted through risky or unprotected sex activity, and a few through kissing, blood transfusions, contaminated clothing, etc. Congenital syphilis is transmitted by a pregnant woman who has syphilis, and the chances of transmission to unborn baby are quite high if a pregnant woman with first or second stage and early latent syphilis.

The LYHER® Syphilis Rapid Test is a lateral flow, serological, immunochromatographic assay for the qualitative detection of IgG or IgM antibodies to Treponema Pallidum (TP) in human whole blood, serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with TP. The test provide early warning and judgment for patients with suspected infections to facilitate prevention and timely treatment.


Post time:Aug-24-2022
  • Previous:
  • Next:
  • Previous:
  • Next:
  • email TOP
    privacy settings Privacy settings
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    ✔ Accepted
    ✔ Accept
    Reject and close
    X